• Mashup Score: 1

    The ISCHEMIA trial was the final nail in the coffin for revascularization in most patients with stable coronary disease. 1 Or was it? A prespecified analysis from the study indicated that complete revascularization in the trial’s invasive arm may have shown greater benefit than conserv ative medical therapy. 2 Researchers randomized 5179 patients with stable coronary disease and at least moderate ischemia without significant left main disease, heart failure with reduced ejection fraction, or New York

    Tweet Tweets with this article
    • RT @mydocwire: A tremendous article written by @CardioNerds founder, @AmitGoyalMD https://t.co/N4N7XEtCib #interventionalcardiology #angina…

  • Mashup Score: 0

    The ISCHEMIA trial was the final nail in the coffin for revascularization in most patients with stable coronary disease. 1 Or was it? A prespecified analysis from the study indicated that complete revascularization in the trial’s invasive arm may have shown greater benefit than conserv ative medical therapy. 2 Researchers randomized 5179 patients with stable coronary disease and at least moderate ischemia without significant left main disease, heart failure with reduced ejection fraction, or New York

    Tweet Tweets with this article
    • A tremendous article written by @CardioNerds founder, @AmitGoyalMD https://t.co/N4N7XEtCib #interventionalcardiology #angina https://t.co/J2q5hmRPj8

  • Mashup Score: 3

    Consult this session to gain insights into the treatment of thrombus in STEMI cases: discover a primary angioplasty trick for managing a thrombus-laden RCA, explore the effectiveness of intracoronary thrombolysis and aspiration thrombectomy, and much more!

    Tweet Tweets with this article
    • STEMI: how to treat the thrombus In this session facilitated by @mmamas1973 & @mauritri view a series of cases shared by your peers 😷, including a primary angioplasty trick in a thrombus-laden right coronary artery & more! https://t.co/02xVdrlxit #interventionalcardiology… https://t.co/40aStTxpvV https://t.co/OI4uIIpQbz

  • Mashup Score: 11

    The 2-day official Course of APSIC is back on 21-22 September 2023 with interactive sessions, hands-on training and its Training Village Programme. Join your global, Asia Pacific Community!

    Tweet Tweets with this article
    • Coming (very) soon to a Congress Centre 🏢 near you: AICT-AsiaPCR, the Official Course of @apsic6 #AictPCR We can't wait to see you in Singapore 🇸🇬 on 21-22 September to learn, shape & share the very best in #interventionalcardiology #cardioed https://t.co/oy0XYGU2kG https://t.co/6XuE5Yld8B

  • Mashup Score: 0

    The SCAI Women in Innovations (WIN) fellowship opportunity is offered to interventional cardiology (IC) fellows or practicing interventional cardiologists interested in pursuing an additional year of advanced training beyond traditional IC fellowships, focusing on complex and high-risk interventional procedures (CHIP) and percutaneous acute mechanical circulatory support training in the cardiac catheterization laboratory. With recent advances in percutaneous coronary intervention (PCI) technology and

    Tweet Tweets with this article
    • SCAI's WIN-CHIP Fellowship offers #InterventionalCardiology fellows or practicing ICs the opportunity to pursue an additional year of advanced training beyond traditional IC fellowships. Please share this post with anyone you know who may be interested ➡️ https://t.co/X1ibA4voEw https://t.co/yLw2s05LT6